FOEHR MATTHEW W (CIK 1237556) reported 21 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-04-07). Recent activity: Buy OABI (36,459 shares), Sell OABI (19,244 shares), Buy OABI (58,333 shares), Sell OABI (30,843 shares), Buy OABI (36,458 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-07 | OmniAb, Inc. (OABI) | President and CEO | Buy | 36,459 | $0 |
| 2026-04-07 | OmniAb, Inc. (OABI) | President and CEO | Sell | 19,244 | $28,674 |
| 2026-02-18 | OmniAb, Inc. (OABI) | President and CEO | Buy | 58,333 | $0 |
| 2026-02-18 | OmniAb, Inc. (OABI) | President and CEO | Sell | 30,843 | $52,742 |
| 2026-02-17 | OmniAb, Inc. (OABI) | President and CEO | Buy | 36,458 | $0 |
| 2026-02-17 | OmniAb, Inc. (OABI) | President and CEO | Sell | 20,754 | $35,282 |
| 2026-01-05 | Viking Therapeutics, Inc. (VKTX) | Director | Buy | 16,000 | $53,280 |
| 2026-01-05 | Viking Therapeutics, Inc. (VKTX) | Director | Sell | 16,000 | $561,760 |
| 2026-01-05 | Viking Therapeutics, Inc. (VKTX) | Director | Buy | 3,150 | $0 |
| 2025-12-09 | OmniAb, Inc. (OABI) | President and CEO | Buy | 26,554 | $0 |
| 2025-12-09 | OmniAb, Inc. (OABI) | President and CEO | Sell | 13,666 | $26,785 |
| 2025-08-26 | OmniAb, Inc. (OABI) | President and CEO | Buy | 540,540 | $999,999 |
| 2025-04-14 | Viking Therapeutics, Inc. (VKTX) | Director | Buy | 20,786 | $166,288 |
| 2025-04-07 | OmniAb, Inc. (OABI) | President and CEO | Buy | 36,458 | $0 |
| 2025-04-07 | OmniAb, Inc. (OABI) | President and CEO | Sell | 19,382 | $38,764 |
| 2025-02-19 | OmniAb, Inc. (OABI) | President and CEO | Buy | 26,549 | $0 |
| 2025-02-19 | OmniAb, Inc. (OABI) | President and CEO | Buy | 36,458 | $0 |
| 2025-02-19 | OmniAb, Inc. (OABI) | President and CEO | Sell | 13,964 | $51,388 |
| 2025-02-19 | OmniAb, Inc. (OABI) | President and CEO | Sell | 19,522 | $71,646 |
| 2025-01-22 | OmniAb, Inc. (OABI) | President and CEO | Buy | 77,003 | $0 |
| 2025-01-22 | OmniAb, Inc. (OABI) | President and CEO | Sell | 41,811 | $135,468 |
Source: SEC Form 4 filings · as of 2026-04-07